Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
beyond that trial and the halted Phase 2 lipodystrophy study, there are no completed human trials measuring body composition, strength, or long-term safety outcomes, so evidence for bodybuilding-related benefit claims remains preliminary and largely extrapolated from the hormone's known biology rather than from direct testing of CJC-1295
9% did not have a detectable substance
The FDA has flagged BPC-157 because of risks like immunogenicity (it could trigger immune reactions), peptide impurities, and lack of human safety data
Treatment for B12 deficiency can be oral, applied under the tongue or administered through the nose, or it may require various types of injections
The Weight Loss Shots Landscape: Where Lipotropics Actually Sit When patients search for weight loss shots, most of them are not thinking about lipotropics at all